Canaccord Raises C3.ai Price Target as Siebel Becomes CEO
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,987 articlesCanaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
Investors eyeing SPRY's Q1 2026 results should understand how to parse a pharma earnings transcript. This guide break...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
Billionaire investor Mark Cuban argues the current economics of AI agents create a meaningful short-term counter to j...
A new round of US-China diplomacy has arrived, but Taiwan's chip giant TSMC remains in the crosshairs. Investors are ...
Abbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
Rigetti Computing leads a two-day rally in quantum stocks as AI-quantum convergence draws attention from investors an...
Pregnancy loss can hit hard emotionally and financially. This guide blends empathy with actionable steps to protect y...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
A year-long selloff in monday.com highlights how a single large exit can ripple through stock prices, risk, and inves...